Conversely, certain mesenchymal and neural malignancies (osteosarcoma, NF1-deficient astrocytoma, and subsets of hepatocellular carcinoma) retain or even upregulate T-cadherin [3]. This evidence concerns the gene CDH13 and hepatocellular carcinoma.